Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Non-Current Assets: 2018-2025

Historic Non-Current Assets for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $2.8 billion.

  • Dr Reddys Laboratories' Non-Current Assets rose 69.99% to $2.8 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $2.8 billion, marking a year-over-year increase of 69.99%. This contributed to the annual value of $2.8 billion for FY2025, which is 69.99% up from last year.
  • Dr Reddys Laboratories' Non-Current Assets amounted to $2.8 billion in FY2025, which was up 69.99% from $1.7 billion recorded in FY2024.
  • Dr Reddys Laboratories' Non-Current Assets' 5-year high stood at $2.8 billion during FY2025, with a 5-year trough of $1.4 billion in FY2023.
  • In the last 3 years, Dr Reddys Laboratories' Non-Current Assets had a median value of $1.7 billion in 2024 and averaged $2.0 billion.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Non-Current Assets fell by 8.73% in 2022, and later surged by 69.99% in 2025.
  • Yearly analysis of 5 years shows Dr Reddys Laboratories' Non-Current Assets stood at $1.6 billion in 2021, then declined by 8.73% to $1.5 billion in 2022, then decreased by 4.44% to $1.4 billion in 2023, then grew by 19.67% to $1.7 billion in 2024, then surged by 69.99% to $2.8 billion in 2025.